Literature DB >> 1593265

Serum protease cleavage of Bacillus anthracis protective antigen.

J W Ezzell1, T G Abshire.   

Abstract

The protective antigen component of anthrax lethal toxin, produced in vitro, has a molecular mass of 83 kDa. Cell-culture studies by others have demonstrated that upon binding of the 83 kDa protective antigen to cell-surface receptors, the protein is cleaved by an unidentified cell-associated protease activity. The resultant 63 kDa protein then binds lethal factor to form lethal toxin, which has been proposed to be internalized by endocytosis. We found that, in the blood of infected animals, the protective antigen exists primarily as a 63 kDa protein and appears to be complexed with the lethal factor component of the toxin. Conversion of protective antigen from 83 to 63 kDa was catalysed by a calcium-dependent, heat-labile serum protease. Except for being complexed to protective antigen, there was no apparent alteration of lethal factor during the course of anthrax infection. The protective antigen-cleaving protease appeared to be ubiquitous among a wide range of animal species, including primates, horses, goats, sheep, dogs, cats and rodents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1593265     DOI: 10.1099/00221287-138-3-543

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  44 in total

1.  Identification of amino acid residues of anthrax protective antigen involved in binding with lethal factor.

Authors:  Vibha Chauhan; Rakesh Bhatnagar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers.

Authors:  Geoffrey K Feld; Katie L Thoren; Alexander F Kintzer; Harry J Sterling; Iok I Tang; Shoshana G Greenberg; Evan R Williams; Bryan A Krantz
Journal:  Nat Struct Mol Biol       Date:  2010-10-31       Impact factor: 15.369

Review 3.  Emerging nanotechnology-based strategies for the identification of microbial pathogenesis.

Authors:  Charalambos Kaittanis; Santimukul Santra; J Manuel Perez
Journal:  Adv Drug Deliv Rev       Date:  2009-11-13       Impact factor: 15.470

Review 4.  Membrane translocation by anthrax toxin.

Authors:  R John Collier
Journal:  Mol Aspects Med       Date:  2009-06-27

5.  Identification of molecular-mimicry-based ligands for cholera diagnostics using magnetic relaxation.

Authors:  Charalambos Kaittanis; Tuhina Banerjee; Santimukul Santra; Oscar J Santiesteban; Ken Teter; J Manuel Perez
Journal:  Bioconjug Chem       Date:  2011-01-12       Impact factor: 4.774

6.  Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma.

Authors:  Alexander F Kintzer; Harry J Sterling; Iok I Tang; Ali Abdul-Gader; Andrew J Miles; B A Wallace; Evan R Williams; Bryan A Krantz
Journal:  J Mol Biol       Date:  2010-04-28       Impact factor: 5.469

7.  Binding and cell intoxication studies of anthrax lethal toxin.

Authors:  Momchilo Vuyisich; Claire K Sanders; Steven W Graves
Journal:  Mol Biol Rep       Date:  2012-01-05       Impact factor: 2.316

8.  Efficient neutralization of antibody-resistant forms of anthrax toxin by a soluble receptor decoy inhibitor.

Authors:  Shilpi Sharma; Diane Thomas; John Marlett; Marianne Manchester; John A T Young
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

9.  Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake.

Authors:  Laurence Abrami; Béatrice Kunz; F Gisou van der Goot
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

Review 10.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.